Violin Jonathan
- SEC CIK
- 0001730615
No open-market purchases or sales filed in the past year.
Current role at each company
- CBIO Crescent Biopharma, Inc.Directoras of Jun 3, 2026
- DNTH Dianthus Therapeutics, Inc.Directoras of May 22, 2026
- ATXS Astria Therapeutics, Inc.Directoras of Jan 23, 2026
- VRDN Viridian Therapeutics, Inc.Chief Executive Officeras of Feb 7, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Violin Jonathan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VRDN Viridian Therapeutics, Inc.
Chief Executive Officer6 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2023 (view filing)6:35 PM ET | Feb 2 | 5 days | Violin JonathanChief Executive Officer | SSale | −50.0K | $36.80 | −$1.84M | −9.4%480.9K after | Amended |
| Jun 2, 2022 (view filing) | Jun 1 | 1 day | Violin JonathanChief Executive Officer | SSale | −30.0K | $12.20 | −$366.0K | −5.9%480.9K after | |
| May 4, 2022 (view filing) | May 2 | 2 days | Violin JonathanChief Executive Officer | SSale | −30.0K | $13.04 | −$391.2K | −5.5%510.9K after | |
| Apr 5, 2022 (view filing) | Apr 1-4 | 4 days | Violin JonathanChief Executive Officer | SSale | −30.0K | $18.92 | −$567.6K | −5.3%540.9K after | 2 lots |
| Mar 3, 2022 (view filing) | Mar 1-2 | 2 days | Violin JonathanChief Executive Officer | SSale | −30.0K | $17.65 | −$529.5K | −5.0%570.9K after | 2 lots |
| Feb 3, 2022 (view filing) | Feb 1-3 | 2 days | Violin JonathanChief Executive Officer | SSale | −30.0K | $19.09 | −$572.8K | −4.8%600.9K after | 3 lots |